angiotensin ii has been researched along with trandolapril in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 9 (40.91) | 18.2507 |
| 2000's | 11 (50.00) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higaki, J; Higashimori, K; Mikami, H; Nagano, M; Nagano, N; Nakamura, F; Ogihara, T | 1 |
| Higaki, J; Higashimori, K; Katahira, K; Mikami, H; Moriguchi, A; Nagano, M; Nakamaru, M; Nakamura, F; Ogihara, T; Tabuchi, Y | 1 |
| Bidiville, J; Brunner, HR; Burnier, M; Juillerat, L; Mooser, V; Nussberger, J; Pauly, N; Waeber, B | 1 |
| Moura, AM; Worcel, M | 1 |
| Brecher, P; Chobanian, AV; Crawford, DC; Farivar, RS | 1 |
| Miyazaki, M; Okunishi, H; Song, K; Takai, S; Tanaka, T | 1 |
| Nasa, Y; Okumura, Y; Sanbe, A; Takeo, S; Toga, W | 1 |
| Benedetti, G; Benigni, A; Corna, D; Maffi, R; Remuzzi, G; Zoja, C | 1 |
| Bartels, GL; de Leeuw, PW; Remme, WJ; van der Ent, M | 1 |
| Miyazaki, M; Sakonjo, H; Takai, S | 2 |
| Maki, T; Nasa, Y; Takahashi, M; Takeo, S; Tanonaka, K; Yoshida, H | 1 |
| Fogari, E; Fogari, R; Malamani, G; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L | 1 |
| Dimayuga, CA; Homma, S; Jorde, UP; Katz, SD; Le Jemtel, TH; Rizkala, A; Vittorio, TJ | 1 |
| Yasuda, H | 1 |
| Wolf, G | 1 |
| Accorsi-Mendonça, D; Corrêa, FM; Oliveira, AM | 1 |
| Fujita, T; Goto, A; Kobayashi, N; Matsuoka, H; Onozato, ML; Tojo, A | 1 |
| Feihl, F; Gojanovic, B; Liaudet, L; Waeber, B | 1 |
| Ahmad, M; Huang, BS; Leenen, FH; Tan, J; White, R | 1 |
| Cervenka, L; Chábová, VČ; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Malý, J; Netuka, I; Opočenský, M; Rakušan, D; Sadowski, J; Schejbalová, S; Skaroupková, P; Vaněčková, I; Vaňourková, Z; Vernerová, Z; Walkowska, A | 1 |
4 review(s) available for angiotensin ii and trandolapril
| Article | Year |
|---|---|
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil | 2002 |
[Diabetic polyneuropathy and ACE gene polymorphism].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Diabetic Neuropathies; Humans; Indoles; Peptidyl-Dipeptidase A; Peripheral Nerves; Polymorphism, Genetic; Quinapril; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrahydroisoquinolines | 2005 |
[The renin-angiotensin-aldosterone system -- more complex as previously thought].
Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Chymases; Clinical Trials as Topic; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Humans; Indoles; Kidney Diseases; Kidney Tubules, Proximal; Losartan; Prospective Studies; Receptors, Angiotensin; Renin-Angiotensin System; Risk Factors; Serine Endopeptidases | 2005 |
Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atenolol; Calcium Channel Blockers; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hypertension; Indoles; Middle Aged; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Sympathetic Nervous System; Verapamil | 2008 |
3 trial(s) available for angiotensin ii and trandolapril
| Article | Year |
|---|---|
Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Indoles; Iodine Radioisotopes; Renin; Renin-Angiotensin System | 1990 |
Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Double-Blind Method; Female; Fibrinolysis; Humans; Hypertension; Indoles; Insulin; Insulin Resistance; Lipids; Losartan; Middle Aged; Plasminogen Activator Inhibitor 1; Postmenopause; Sensitivity and Specificity; Women's Health | 2001 |
Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Double-Blind Method; Enalapril; Endothelium, Vascular; Exercise Tolerance; Female; Heart Failure; Humans; Indoles; Male; Middle Aged; Renin-Angiotensin System | 2004 |
15 other study(ies) available for angiotensin ii and trandolapril
| Article | Year |
|---|---|
Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hydralazine; Indoles; Isoproterenol; Male; Myocardium; Nephrectomy; Rats; Rats, Inbred Strains; Renin | 1992 |
Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Enalapril; Heart Atria; Heart Ventricles; Indoles; Male; Myocardium; Organ Size; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1991 |
[Ex vivo and in vitro effects of trandolapril on the efflux of 22Na from the caudal artery of the SHR rat. Inhibition of vascular angiotensin II production].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Cell Membrane; Enalapril; Hypertension; Indoles; Male; Ouabain; Rats; Rats, Inbred SHR; Saralasin; Sodium; Sodium Radioisotopes; Tail | 1988 |
Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blotting, Northern; Fibrosis; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart; Imidazoles; Indoles; Losartan; Male; Myocardium; Phenylephrine; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Renin-Angiotensin System; RNA; Tetrazoles | 1995 |
Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice.
Topics: Administration, Oral; Analgesics; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Brain; Enalapril; Imidazoles; Indoles; Losartan; Male; Mice; Naloxone; Pain Measurement; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Tetrazoles | 1996 |
Effects of long-term treatment with trandolapril on augmented vasoconstriction in rats with chronic heart failure.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Vessels; Culture Techniques; Disease Models, Animal; Drug Interactions; Heart Failure; Hemodynamics; Indoles; Male; Muscle, Smooth, Vascular; Norepinephrine; Prostaglandins F; Rats; Rats, Wistar; Reference Values; Vasoconstriction; Vasoconstrictor Agents | 1996 |
Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.
Topics: Angiotensin II; Animals; Blood Pressure; Endothelin-1; Glomerulonephritis; Indoles; Kidney; Male; Phenylpropionates; Proteinuria; Pyrimidines; Rats; Rats, Sprague-Dawley | 1998 |
Renal hemodynamic effects in patients with moderate to severe heart failure during chronic treatment with trandolapril.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Digoxin; Diuretics; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Indoles; Kidney; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Pulmonary Wedge Pressure; Renal Circulation; Renin; Time Factors | 1998 |
Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Arteriosclerosis; Biphenyl Compounds; Cholesterol, Dietary; Female; Imidazoles; Indoles; Macaca fascicularis; Male; Peptidyl-Dipeptidase A | 1999 |
Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Chronic Disease; Collagen; Dose-Response Relationship, Drug; Fibroblasts; GTP-Binding Proteins; Heart; Heart Failure; Heart Septum; Heart Ventricles; Hemodynamics; Imidazoles; Indoles; Lung; Male; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 2001 |
Beneficial effect of trandolapril on the lifespan of a severe hypertensive model.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Body Weight; Brain; Hypertension; Indoles; Kidney; Male; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sodium Chloride, Dietary; Survival Analysis | 2001 |
B(2)-receptor modulation of the reactivity to phenylephrine and angiotensin II in the carotid artery of normotensive rats after trandolapril treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Carotid Arteries; Endothelium; In Vitro Techniques; Indoles; Indomethacin; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2 | 2006 |
Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Drug Synergism; Eplerenone; Hypertension; Indoles; Kidney; Male; Mineralocorticoid Receptor Antagonists; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium-Potassium-Exchanging ATPase; Spironolactone; Superoxide Dismutase; Transforming Growth Factor beta | 2007 |
Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Baroreflex; Brain; Fibrosis; Hemodynamics; Indoles; Infusions, Intravenous; Injections, Subcutaneous; Kidney; Lisinopril; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Renin-Angiotensin System; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2008 |
Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Furosemide; Hydrochlorothiazide; Hypertension; Indoles; Kidney Failure, Chronic; Labetalol; Losartan; Proteinuria; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Renin-Angiotensin System | 2010 |